Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on LTR Pharma.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps Lunch Wrap: Earnings in full swing as CSL tumbles, Temple and Webster skyrockets 27pc
Health & Biotech
ASX Health Stocks: Anteris plans for US IPO and listing on Nasdaq
Health & Biotech
ASX Health Stocks: Big tick for Cynata’s stem-cell therapy
Investor Guides
Investor Guide: Health & Biotech FY2025 featuring Tim Boreham
News
Closing Bell: ASX, Nikkei fight back; RBA refuses to budge on interest rates
Stockhead TV
Break it Down: LTR Pharma prescribes ED spray under TGA scheme
Health & Biotech
Patients uplifted by LTR Pharma’s ED treatment Spontan under TGA scheme
Health & Biotech
ASX Health Stocks: PYC’s visionary drug shows promise; Spontan ED spray available under TGA program
Health & Biotech
ScoPo’s Powerplays: ASX health stocks up in ‘fairly lacklustre week’
Health & Biotech
LTR Pharma raises $10.5m to advance erectile dysfunction treatment SPONTAN
Health & Biotech
The ASX biotechs with secured FDA clearances in 2024, and others looking likely
News
Closing Bell: Most ASX sectors flashing red today, as RAU makes solid market debut
News
ASX Small Caps Lunch Wrap: Has science unveiled Australia’s ultimate Murder Bird this week?
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Joy as LTR Pharma stands proud and delight as ASX diggers inject miner surprise
News
